Scarring Alopecia: When a Hair Transplant Won’t Work

The consultation that stays with you is not the one where you say yes. It is the one where a patient has flown in, has photographs of a hairline they want back, and the scalp under the light tells you that operating would take their money and give them nothing.

Most hair loss is a follicle that shrinks. This one is a follicle that is destroyed and replaced by scar tissue, and that difference decides everything that follows.

The short answer: in scarring alopecia — also called cicatricial alopecia — inflammation permanently destroys the follicle and the stem cells that would have regrown it, so the hair cannot return on its own. A hair transplant into actively inflamed scalp usually fails, because the same process attacks the new grafts. Surgery becomes possible only when the disease has been quiet for 1 to 2 years, confirmed by a dermatologist, and even then graft survival is lower than in normal scalp and a small test session is the sensible first step.

What “scarring” actually means at follicle level

The word makes people picture a visible scar from an injury. What is meant here is microscopic. An inflammatory process targets the upper part of the follicle, where the stem cells that regenerate the hair live. Once those cells are gone, the follicle cannot rebuild itself and the space fills with fibrous tissue.

This is why the distinction matters more than any other in hair medicine. In pattern hair loss the follicle is still present, just miniaturised, which is why medication can partly reverse it. In scarring disease the follicle is not there at all.

The clinical consequence is blunt. Every month that active inflammation continues, more follicles are permanently lost. Time is not neutral here, and the priority is not a hairline plan but stopping the process.

How to tell scarring from ordinary hair loss

You cannot diagnose yourself, but there are signals that should send you to a dermatologist rather than a surgical consultation.

Look at the skin, not the hair. In scarring alopecia the affected scalp often looks smooth, shiny and pale, and crucially the follicular openings — the tiny pores you can normally see — are absent. Non-scarring loss leaves the pores visible even where hair is thin.

Other warning signs are redness or scaling around individual hairs, hairs emerging in tufts from a single opening, an itchy, burning or tender scalp, and a border that moves in an unusual direction such as a hairline receding evenly in a band including the temples and sideburns. Pain and itch are particularly important, because pattern hair loss does not hurt.

Frontal fibrosing alopecia: the one that is rising

Frontal fibrosing alopecia was rare thirty years ago and is now seen frequently, overwhelmingly in postmenopausal women. It produces a band of recession along the frontal hairline that moves backwards evenly, taking the sideburns with it, and it very often removes the eyebrows first.

Two features distinguish it from the female pattern loss it is mistaken for. The skin in the receded band looks pale and shiny compared with the forehead below it, and single “lonely hairs” are often left stranded in the bare zone. Eyebrow loss preceding scalp change is a strong clue.

It is treatable in the sense that progression can often be slowed, which is exactly why early dermatological referral matters so much. Transplanting a hairline while this is active is one of the more painful mistakes in the field, because the grafts are placed directly into the advancing front of the disease.

Lichen planopilaris

Lichen planopilaris is closely related, and frontal fibrosing alopecia is generally regarded as a variant of it. It produces patchy loss anywhere on the scalp, often at the crown, with redness and scaling around the follicle openings and frequently with itching, burning or tenderness.

Patients describe it as loss that “feels” different — a sore or crawling sensation that pattern loss does not produce. Hairs at the edge of the patch often pull out easily, which is a sign of active disease rather than normal shedding.

Because the areas can look like ordinary thinning at a glance, this is one of the conditions most often missed until a photograph from two years earlier is compared. If your loss itches or hurts, say so — it changes the entire diagnostic direction.

Central centrifugal cicatricial alopecia

CCCA starts at the crown and spreads outwards in a circle, and it affects women of African descent far more than any other group. It often begins with tenderness or itching and a subtle loss of density at the vertex, long before an obvious bald area appears.

Genetics, hair-shaft fragility and years of tension or heat styling are all discussed as contributors, and the honest position is that the cause is not fully settled. What is clear is that early diagnosis changes the outcome, because treatment can preserve what remains even though it cannot restore what is gone.

Textured hair adds specific surgical considerations even in patients who are eventually candidates, which we cover on our afro hair transplant page. But the sequence is always dermatology first: no surgical plan should be written for a crown that is still inflamed.

Folliculitis decalvans and dissecting cellulitis

These two are neutrophilic scarring alopecias, and they look and behave differently from the lymphocytic group above. Folliculitis decalvans produces pustules, crusting and tufted hairs — several shafts emerging from one opening, sometimes described as doll’s hair.

Dissecting cellulitis produces boggy nodules and sinus tracts, most often at the crown and back of the scalp, and it is associated with hidradenitis suppurativa and severe acne. Both are more common in men, and both cause visible, sometimes distressing damage.

Medical management is prolonged and specialist-led, often involving long antibiotic or immunomodulatory courses that must be prescribed and monitored by a physician. Surgery is only ever discussed after prolonged remission, and even then cautiously.

Traction alopecia: the one that crosses the line

Traction alopecia starts as a non-scarring condition. Years of tight braids, weaves, extensions or a tightly pulled bun place constant tension on the follicle, and if the tension stops early enough, the hair recovers.

Left long enough, it becomes scarring. That is the critical point patients are rarely told about: the same habit that causes reversible loss at year three causes permanent loss at year ten. The classic pattern is loss along the frontal and temporal margins with a retained fringe of fine hairs at the very edge.

This is the one scarring-spectrum condition where transplantation frequently works well, provided the tension has stopped and the process is inactive. We set out realistic expectations in hair transplants for women with traction alopecia.

Why a biopsy is the decision-maker

A scalp biopsy is a small procedure taking a few millimetres of skin under local anaesthetic, and it is the only way to confirm what type of process is happening and whether it is still active.

This matters because the treatment paths are opposite. Active inflammation needs suppression, usually with topical or intralesional steroids, or systemic medication in more aggressive cases — always prescribed and monitored by a dermatologist. Surgery in that situation is not just useless, it is actively harmful, because the trauma of grafting can trigger a flare.

A responsible clinic asks for that biopsy result before planning anything. If a clinic looks at photographs of an inflamed, shiny hairline and quotes you a graft number, that is the moment to walk away — a point we make more generally in what a hair transplant cannot fix.

Why grafts fail in active disease

Three things work against the grafts at once. The recipient bed is fibrous tissue with reduced blood supply, so fewer grafts survive purely on vascular grounds. The immune process that destroyed the original follicles can target transplanted ones, which are not immune simply because they came from elsewhere. And surgical trauma itself can act as a trigger.

The result is a poor outcome that also consumed permanent donor hair. That is the part patients underestimate. Donor supply is finite; grafts lost in a failed procedure are gone from a lifetime budget, and they cannot be re-harvested.

This is why we would rather turn a patient away than take a case that has a low chance of working. It costs bookings. It also prevents the far worse conversation two years later, when the grafts have gone, the disease has advanced and the donor area has already been spent on an area that could never have held them.

When a transplant can work

There is a real group of patients who can be treated, and it deserves to be stated clearly rather than lost in the warnings.

The conditions are: a confirmed diagnosis, disease that has shown no clinical or biopsy evidence of activity for a sustained period, a dermatologist who agrees the process is burnt out, and a patient who understands that graft survival will be lower than in normal scalp. Most experienced surgeons want 1 to 2 years of documented stability before operating.

A small test session — a few hundred grafts into part of the affected area, then a wait of eight to twelve months — is the sensible approach. If those grafts survive and no flare occurs, a larger session can follow. If they do not, you have lost a small number of grafts rather than a large one.

How long “burnt out” really needs to be

There is no universal number, and anyone who gives you one with confidence is guessing. What surgeons look for is a combination: no new loss on standardised photographs, no symptoms of itching, burning or tenderness, no redness or scaling around follicles on examination, and ideally a repeat biopsy showing no active inflammation.

Stability that has held through a period without treatment is more convincing than stability maintained on suppressive medication, though the latter can still be acceptable with dermatological support.

The reason for the caution is that these conditions can relapse after years of quiet. That risk never reaches zero, which is why the conversation before surgery has to include what happens if the disease returns after grafting — an outcome we discuss openly rather than hiding in a consent form.

Why the diagnosis so often takes years

The average patient we see with a confirmed scarring diagnosis waited a long time for it, and the delay follows a familiar sequence.

Early on, the loss looks like everything else. A woman notices thinning at the front and is told it is stress, or hormones, or her age. She buys a supplement, changes shampoo, waits a year. By the time she is examined properly, a band of hairline has gone and the follicles in it are unrecoverable.

Two things drive the delay. The first is that these conditions are still under-recognised outside dermatology, and the early appearance is subtle — mild redness, a slightly shiny margin, a few tufted hairs. The second is that patients present to the wrong place. Someone worried about a receding hairline books a hair transplant consultation, not a dermatology appointment, and a clinic focused on selling surgery has no incentive to slow that down.

The practical takeaway is simple. If your hair loss itches, burns, hurts or looks shiny where the hair used to be, get a dermatological assessment before you get a graft quotation. Months matter in this diagnosis in a way they do not in pattern hair loss, because every month of untreated inflammation is follicles that no surgeon can ever put back.

What we do at Hairpol when we suspect scarring

The first thing we do is stop the sales conversation. If the photographs show shiny skin, absent pore openings, an unusual border, or the patient reports itching, burning or tenderness, we say so directly and explain why the next appointment should be with a dermatologist rather than with us.

We ask for a biopsy report and a dermatologist’s opinion on activity, and we ask for the history: when it started, how fast it moved, whether it itches, what treatment has been tried. We also check the basics that can coexist — thyroid and iron status, using the panel described in the blood tests for hair loss.

Where the picture is unclear, the honest answer is a review in six to twelve months with standardised photographs. If you want a second opinion on whether what you have looks scarring or not, you can send photographs for an assessment before booking anything or buying a flight.

How this differs from alopecia areata

Patients frequently conflate the two, and they could hardly be more different. Alopecia areata is autoimmune but non-scarring: the follicle survives, the pores remain visible, and hair can return spontaneously even after years.

Scarring alopecia destroys the follicle. Nothing returns spontaneously, because there is nothing left to return from. The reason both are usually surgical exclusions is different in each case — areata because the immune process is unpredictable and can attack grafts, scarring disease because the recipient bed itself is damaged.

We explain the areata picture separately in alopecia areata versus pattern hair loss. Confusing the two leads people to wait for regrowth that will never come, or to write off hair that would have returned on its own.

What can be done when surgery is not possible

Being told you are not a surgical candidate is not the end of the conversation, though it often feels like it in the room.

Medical treatment to halt progression is the priority and genuinely changes outcomes, because every follicle preserved is one that does not need replacing. Beyond that, non-surgical support for the remaining hair through our hair treatments can be discussed once a dermatologist confirms the scalp is quiet, and scalp micropigmentation gives a cosmetic option for stable areas without risking donor supply.

Camouflage products, careful styling and, for women, a review of the wider hormonal and nutritional picture through our women’s hair restoration service all have a place. None of it is what the patient came for. All of it is better than a failed operation.

If another clinic has already told you yes

This happens often enough that it is worth addressing directly. A patient with obvious signs of a scarring process is quoted a graft number by a clinic that never asked about itching, never looked for pore openings and never requested a biopsy.

Before you commit, ask three questions. What is my diagnosis, and how was it established? Is there any evidence the disease is inactive? What happens to my grafts if it flares after surgery? A clinic that cannot answer those clearly has not assessed you properly, whatever the photographs on its website look like.

Then get a dermatological opinion independently of any clinic that wants to operate on you. If you would like a second view on your photographs first, our contact page and our frequently asked questions are the place to start. Being told no by someone with nothing to gain is worth more than being told yes by someone with everything to gain.